Furthermore, CRP is correlated with blood interleukin-6 (IL-6) levels, a marker that reflects tumor growth activity.17 Thus, CRP levels in patients with cancer may reflect both tumor burden and grade. This evidence concerns the gene CRP and neoplasm.